Citi Starts Regeneron Pharma (REGN) at Buy
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $840.84 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 19
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 19
Join SI Premium – FREE
Citi initiated coverage on Regeneron Pharma (NASDAQ: REGN) with a Buy rating and a price target of $480.00.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $393.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Regeneron's Pasatru for rare bone disorder FOP
- Canaccord Starts Incyte (INCY) at Buy
- Piper Sandler Starts Sphere Entertainment (SPHR) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
